163 related articles for article (PubMed ID: 25380867)
1. Anti-human leukocyte antigen antibodies are present in blood of blood donors: is therapy with blood preparations safe for graft recipients?
Nowosiad-Magda M; Myślak M; Roszkowska P; Borowiec-Chłopek Z; Krasnodębska-Szponder B; Kłosińska E; Agapow A; Giedrys-Kalemba S
Transplant Proc; 2014 Oct; 46(8):2565-71. PubMed ID: 25380867
[TBL] [Abstract][Full Text] [Related]
2. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy.
Triulzi DJ; Kleinman S; Kakaiya RM; Busch MP; Norris PJ; Steele WR; Glynn SA; Hillyer CD; Carey P; Gottschall JL; Murphy EL; Rios JA; Ness PM; Wright DJ; Carrick D; Schreiber GB
Transfusion; 2009 Sep; 49(9):1825-35. PubMed ID: 19453983
[TBL] [Abstract][Full Text] [Related]
3. Identification of specificities of antibodies against human leukocyte antigens in blood donors.
Endres RO; Kleinman SH; Carrick DM; Steele WR; Wright DJ; Norris PJ; Triulzi D; Kakaiya R; Busch MP;
Transfusion; 2010 Aug; 50(8):1749-60. PubMed ID: 20158682
[TBL] [Abstract][Full Text] [Related]
4. The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or -negative components.
Kleinman SH; Triulzi DJ; Murphy EL; Carey PM; Gottschall JL; Roback JD; Carrick D; Mathew S; Wright DJ; Cable R; Ness P; Gajic O; Hubmayr RD; Looney MR; Kakaiya RM;
Transfusion; 2011 Oct; 51(10):2078-91. PubMed ID: 21446938
[TBL] [Abstract][Full Text] [Related]
5. Analysis of specificity of anti-human leukocyte antigen antibodies in kidney recipients in reference to clinical outcome.
Nowosiad-Magda M; Myślak M; Roszkowska P; Borowiec-Chłopek Z; Urasińska E; Różański J; Domański L; Ciechanowski K; Giedrys-Kalemba S
Transplant Proc; 2014 Oct; 46(8):2606-12. PubMed ID: 25380877
[TBL] [Abstract][Full Text] [Related]
6. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors.
Kakaiya RM; Triulzi DJ; Wright DJ; Steele WR; Kleinman SH; Busch MP; Norris PJ; Hillyer CD; Gottschall JL; Rios JA; Carey P; Glynn SA;
Transfusion; 2010 Jun; 50(6):1328-34. PubMed ID: 20070615
[TBL] [Abstract][Full Text] [Related]
8. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
9. Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome.
Quillen K; Medrano C; Adams S; Peterson B; Hackett J; Leitman SF; Klein HG; Stroncek DF
Transfusion; 2011 Mar; 51(3):504-10. PubMed ID: 20849407
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of leucocyte alloantibodies in blood donors from South China.
Xia W; Ye X; Xu X; Chen D; Deng J; Chen Y; Ding H; Shao Y; Wang J; Liu J; Li H; Huang YF; Fu Y; Santoso S
Transfus Med; 2015 Dec; 25(6):385-92. PubMed ID: 26876912
[TBL] [Abstract][Full Text] [Related]
11. Establishing assay cutoffs for HLA antibody screening of apheresis donors.
Carrick DM; Norris PJ; Endres RO; Pandey S; Kleinman SH; Wright D; Sun Y; Busch MP;
Transfusion; 2011 Oct; 51(10):2092-101. PubMed ID: 21332726
[TBL] [Abstract][Full Text] [Related]
12. Anti-leucocyte antibodies in platelet apheresis donors with and without prior immunizing events: implications for TRALI prevention.
Sigle JP; Thierbach J; Infanti L; Muriset M; Hunziker G; Chassot K; Niederhauser C; Gowland P; Holbro A; Sunic K; Buser A; Fontana S
Vox Sang; 2013 Oct; 105(3):244-52. PubMed ID: 23773018
[TBL] [Abstract][Full Text] [Related]
13. Acute non-hemolytic transfusion reactions and HLA class I antibody: advantages of solid phase assay compared with conventional complement-dependent assay.
Imoto S; Kawamura K; Tokumine Y; Araki N; Akita S; Nishimura C; Inaba H; Saigo K; Mabuchi O; Okazaki H
Transfus Med; 2010 Apr; 20(2):95-103. PubMed ID: 19883399
[TBL] [Abstract][Full Text] [Related]
14. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
Saw CL; Hannach B; Petrazsko T; Nickerson P
Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
[TBL] [Abstract][Full Text] [Related]
15. Are we underestimating reverse TRALI?
De Clippel D; Emonds MP; Compernolle V
Transfusion; 2019 Sep; 59(9):2788-2793. PubMed ID: 31241780
[TBL] [Abstract][Full Text] [Related]
16. Impact of using different laboratory assays to detect human leukocyte antigen antibodies in female blood donors.
Lopes LB; Fabron A; Chiba AK; Ruiz MO; Bordin JO
Transfusion; 2010 Apr; 50(4):902-8. PubMed ID: 20003053
[TBL] [Abstract][Full Text] [Related]
17. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
18. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
20. Value of donor-specific antibody detection in first-graft renal transplant recipients with a negative complement-dependent cytotoxic crossmatch.
Mahmoud KM; Ismail AM; Sheashaa HA; Gheith OA; Kamal MM; Ghoneim MA
Exp Clin Transplant; 2009 Jun; 7(2):124-8. PubMed ID: 19715518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
